Company Reata Pharmaceuticals, Inc.
Equities
RETA
US75615P1030
Biotechnology & Medical Research
Business Summary
Number of employees: 322
Managers
Managers | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director of Finance/CFO | 60 | 23-09-25 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Mike Visnick
PRN | Corporate Officer/Principal | - | 06-12-31 |
Robin Kral
PRN | Corporate Officer/Principal | - | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director/Board Member | - | 23-09-25 | |
Michael Dambach
BRD | Director/Board Member | - | 23-09-25 |
Robin Kramer
BRD | Director/Board Member | - | 23-09-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 3 | 4,515,246 | 0 | 0 | 75.54 % |
Stock B | 1 | 33,331,586 | 28,588,243 ( 85.77 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |